Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Drug discovery in pharmaceutical industry: productivity challenges and trends.

Khanna I.

Drug Discov Today. 2012 Oct;17(19-20):1088-102. doi: 10.1016/j.drudis.2012.05.007. Epub 2012 May 22. Review.

PMID:
22627006
[PubMed - indexed for MEDLINE]
2.

How the pill became a lifestyle drug: the pharmaceutical industry and birth control in the United States since 1960.

Watkins ES.

Am J Public Health. 2012 Aug;102(8):1462-72. doi: 10.2105/AJPH.2012.300706. Epub 2012 Jun 14.

PMID:
22698049
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Public perceptions of the pharmaceutical industry and drug safety: implications for the pharmacovigilance professional and the culture of safety.

Olsen AK, Whalen MD.

Drug Saf. 2009;32(10):805-10. doi: 10.2165/11316620-000000000-00000.

PMID:
19722724
[PubMed - indexed for MEDLINE]
4.

Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.

Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA.

Chem Res Toxicol. 2004 Jan;17(1):3-16. Review. Erratum in: Chem Res Toxicol. 2005 Nov;18(11):1777.

PMID:
14727914
[PubMed - indexed for MEDLINE]
5.
6.

Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions.

Yuan R, Madani S, Wei XX, Reynolds K, Huang SM.

Drug Metab Dispos. 2002 Dec;30(12):1311-9.

PMID:
12433797
[PubMed - indexed for MEDLINE]
Free Article
7.

Drug discovery: new models for industry-academic partnerships.

Tralau-Stewart CJ, Wyatt CA, Kleyn DE, Ayad A.

Drug Discov Today. 2009 Jan;14(1-2):95-101. doi: 10.1016/j.drudis.2008.10.003. Epub 2008 Nov 21. Review.

PMID:
18992364
[PubMed - indexed for MEDLINE]
8.

Overview of the animal health drug development and registration process: an industry perspective.

Hunter RP, Shryock TR, Cox BR, Butler RM, Hammelman JE.

Future Med Chem. 2011 May;3(7):881-6. doi: 10.4155/fmc.11.55.

PMID:
21644833
[PubMed - indexed for MEDLINE]
9.

Foundation Review: Transgenic animals and their impact on the drug discovery industry.

Dunn DA, Pinkert CA, Kooyman DL.

Drug Discov Today. 2005 Jun 1;10(11):757-67. Review.

PMID:
15922934
[PubMed - indexed for MEDLINE]
10.

High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.

Buckley LA, Dorato MA.

Regul Toxicol Pharmacol. 2009 Aug;54(3):301-7. doi: 10.1016/j.yrtph.2009.05.015. Epub 2009 May 27.

PMID:
19477212
[PubMed - indexed for MEDLINE]
11.

Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.

Khan NA, Lombeida JI, Singh M, Spencer HJ, Torralba KD.

Arthritis Rheum. 2012 Jul;64(7):2059-67. doi: 10.1002/art.34393.

PMID:
22275179
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

An assessment of drug testing within the construction industry.

Gerber JK, Yacoubian GS Jr.

J Drug Educ. 2002;32(1):53-68.

PMID:
12096557
[PubMed - indexed for MEDLINE]
13.

Drug-drug interaction studies: regulatory guidance and an industry perspective.

Prueksaritanont T, Chu X, Gibson C, Cui D, Yee KL, Ballard J, Cabalu T, Hochman J.

AAPS J. 2013 Jul;15(3):629-45. doi: 10.1208/s12248-013-9470-x. Epub 2013 Mar 30. Review.

PMID:
23543602
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Investigating mitochondrial dysfunction to increase drug safety in the pharmaceutical industry.

Nadanaciva S, Will Y.

Curr Drug Targets. 2011 Jun;12(6):774-82. Review.

PMID:
21275886
[PubMed - indexed for MEDLINE]
15.

Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.

Raman NV, Prasad AV, Ratnakar Reddy K.

J Pharm Biomed Anal. 2011 Jun 25;55(4):662-7. doi: 10.1016/j.jpba.2010.11.039. Epub 2010 Dec 3. Review.

PMID:
21193280
[PubMed - indexed for MEDLINE]
16.

The path to oncology drug target validation: an industry perspective.

Cort├ęs-Cros M, Schmelzle T, Stucke VM, Hofmann F.

Methods Mol Biol. 2013;986:3-13. doi: 10.1007/978-1-62703-311-4_1.

PMID:
23436402
[PubMed - indexed for MEDLINE]
17.

The US drug safety system: role of the pharmaceutical industry.

Gibson BR, Suh R, Tilson H.

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):110-4.

PMID:
17724741
[PubMed - indexed for MEDLINE]
18.

The role of the intestine in drug metabolism and pharmacokinetics: an industry perspective.

Fisher MB, Labissiere G.

Curr Drug Metab. 2007 Oct;8(7):694-9. Review.

PMID:
17979657
[PubMed - indexed for MEDLINE]
19.

Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B.

BMJ. 2003 May 31;326(7400):1171-3. Review.

PMID:
12775615
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Recent natural products based drug development: a pharmaceutical industry perspective.

Shu YZ.

J Nat Prod. 1998 Aug;61(8):1053-71. Review. No abstract available.

PMID:
9722499
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk